US Government Calls For Additional 200M Doses Of Pfizer-BioNTech COVID Shot

by Vandana Singh, Benzinga Editor

July 23, 2021 7:57 AM | 1 min read |

The U.S. government has purchased an additional 200 million doses of the Pfizer Inc PFE - BioNTech SE BNTX COVID-19 Vaccine.
The incremental doses will be delivered from October 2021 through April 2022.
The order of additional doses brings the companies' total number of doses to the U.S. government under its existing supply agreement to 500 million.
The companies expect to deliver 110 million of the additional doses by December 31, 2021, with the remaining 90 million doses delivered by April 30, 2022.
The U.S. government also can acquire the booster shots targeting potential variants and new formulations of the vaccine, if available and authorized.
Price Action: BNTX shares are up 1.18% at $284.21, while PFE shares are down 0.14% at $41.41 during the premarket session on the last check Friday.
Photo by x3 from Pixabay

Posted In: Biotech Government News Health Care Contracts General Briefs COVID-19 Vaccine

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.